Richard S. Morris's most recent trade in Carisma Therapeutics Inc was a trade of 85,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 17, 2024.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Carisma Therapeutics Inc | Richard S. Morris | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Jun 2024 | 85,000 | 85,000 | - | - | Stock Option (Right to Buy) | |
| Carisma Therapeutics Inc | Morris S. Richard | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 31 Jan 2024 | 170,500 | 170,500 | - | - | Stock Option (Right to Buy) | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 300 | 0 | - | - | Restricted Stock Unit | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 07 Jun 2023 | 300 | 31,500 (0%) | 0% | 0 | Common Stock | |
| Carisma Therapeutics Inc | Richard S. Morris | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 238,000 | 238,000 | - | - | Stock Option (Right to Buy) | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,500 | 31,200 (0%) | 0% | 0 | Common Stock | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Apr 2023 | 1,500 | 0 | - | - | Restricted Stock Unit | |
| McGrath Rentcorp | Smith Richard Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 24 Feb 2023 | 1,200 | 1,200 | - | - | Restricted Stock Unit | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 1,500 | 0 | - | - | Restricted Stock Unit | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2022 | 1,500 | 29,700 (0%) | 0% | 0 | Common Stock | |
| McGrath Rentcorp | Smith Richard Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2022 | 1,500 | 1,500 | - | - | Restricted Stock Unit | |
| Passage Bio Inc | Richard S. Morris | Chief Financial Officer | Purchase of securities on an exchange or from another person at price $ 13.82 per share. | 21 May 2021 | 2,171 | 5,454 (0%) | 0% | 13.8 | 30,000 | Common Stock |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 1,700 | 0 | - | - | Restricted Stock Unit | |
| McGrath Rentcorp | Smith Richard Morris | Director | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Apr 2021 | 1,700 | 28,200 (0%) | 0% | 0 | Common Stock | |
| McGrath Rentcorp | Smith Richard Morris | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 25 Feb 2021 | 1,500 | 1,500 | - | - | Restricted Stock Units | |
| Passage Bio Inc | Richard S. Morris | Chief Financial Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 16 Feb 2021 | 50,000 | 50,000 | - | - | Stock Option (right to buy) |